Sunday, 12 July 2020

w west

Britain: A clinical trial of the vaccine against the emerging coronavirus The vaccine name is "ChAdOx1 nCoV-19".

Britain: A clinical trial of the vaccine against the emerging coronavirus

Abu Dhabi, United Arab Emirates:- Scientists at the University of Oxford have started a clinical trial of the vaccine against the emerging coronavirus (Covid 19), and those involved in the medical project confirm that the success rate is very promising and has reached nearly 80 percent.

The authorities will provide an additional £ 20 million in support for both the current Oxford University experience and another at Imperial College London.

And waiting for the Oxford laboratory to start producing this vaccine before the end of the testing phase, the goal is to have a million doses ready before September.

Britain will invest in the structures capable of producing this vaccine, so that it can be made available as soon as possible if the trials are successful.

Despite the progress made by scientists in developing the vaccine against the Corona virus, which appeared in China and then turned into a global pandemic.

This vaccine is known in the medical community as "ChAdOx1 nCoV-19", and it was developed from a harmless virus from a chimpanzee, and then genetically modified to carry part of the Corona virus. This technique showed, earlier, that it significantly strengthens immunity in the face of other diseases.

Contracts were concluded with three British companies, as well as other companies abroad, for the production of the vaccine.

Jenner Institute researcher Sarah Gilbert said more than 500,000 people will have undergone vaccine testing by mid-May.

Poll

The political war in Tunisia
« July 2020 »
Mon Tue Wed Thu Fri Sat Sun
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

To contact and communicate with all officials of all departments of the Egyptian News Vision Group

Email:

visionamagazine.top@gmail.com

Fax:

+20 13 3 220 814
Toggle Bar